Early intervention can put a stop to negative side effects before they escalate
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound have completely changed the conversation around weight loss and metabolic health
The inability to sustain weight loss may be due to PYY 3-36 -induced Y2-R down-regulation and tolerance (i.e., tachyphylaxis) and/or activation of compensatory mechanisms in response to reduced food intake
In addition, there are dual GLP-1/GIP receptor agonists such as tirzepatide
Manish Sahni, MD is essential for appropriate use, dosage guidance, and monitoring for effectiveness and safety
Whole-Body Metabolic Coordination Through combined hormonal, neurological, and gastrointestinal effects[4], GLP-1 for weight loss medications create a synchronized metabolic response